Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VINILO trial of vinblastine plus nilotinib for pediatric low-grade glioma
NL-OMON47673Phase 2Not yet recruiting
- Sponsor
- Gustave Roussy
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vinblastine and nilotinib in glioma and low-grade glioma (LGG) (3 arms), sponsored by Gustave Roussy. Primary endpoints: Phase I dose-limiting toxicity and Progression-free survival. Planned start Sep 2013; status: not yet recruiting.
02
Drugs
vinblastinenilotinib
03
Conditions
gliomalow-grade glioma (LGG)
Beyond the preview
Go deeper on NL-OMON47673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47673.